(3R)-3-HYDROXYDODECANOIC ACID

Identification

Generic Name
(3R)-3-HYDROXYDODECANOIC ACID
DrugBank Accession Number
DB07930
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 216.3172
Monoisotopic: 216.172544634
Chemical Formula
C12H24O3
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UPeroxisomal acyl-coenzyme A oxidase 1Not AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
PathwayCategory
Fatty Acid BiosynthesisMetabolic
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as medium-chain hydroxy acids and derivatives. These are hydroxy acids with a 6 to 12 carbon atoms long side chain.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Hydroxy acids and derivatives
Sub Class
Medium-chain hydroxy acids and derivatives
Direct Parent
Medium-chain hydroxy acids and derivatives
Alternative Parents
Medium-chain fatty acids / Hydroxy fatty acids / Beta hydroxy acids and derivatives / Secondary alcohols / Monocarboxylic acids and derivatives / Carboxylic acids / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
Substituents
Alcohol / Aliphatic acyclic compound / Beta-hydroxy acid / Carbonyl group / Carboxylic acid / Carboxylic acid derivative / Fatty acid / Fatty acyl / Hydrocarbon derivative / Hydroxy fatty acid
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
(3R)-3-hydroxy fatty acid, 3-hydroxylauric acid (CHEBI:43197) / Hydroxy fatty acids (LMFA01050251)
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available
InChI Key
MUCMKTPAZLSKTL-LLVKDONJSA-N
InChI
InChI=1S/C12H24O3/c1-2-3-4-5-6-7-8-9-11(13)10-12(14)15/h11,13H,2-10H2,1H3,(H,14,15)/t11-/m1/s1
IUPAC Name
(3R)-3-hydroxydodecanoic acid
SMILES
[H][C@@](O)(CCCCCCCCC)CC(O)=O

References

General References
Not Available
Human Metabolome Database
HMDB0010728
PubChem Compound
5312804
PubChem Substance
99444401
ChemSpider
4472229
ChEBI
43197
ChEMBL
CHEMBL1233457
ZINC
ZINC000016051927
PDBe Ligand
HXD
PDB Entries
2ddh / 4wx0 / 8j18

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.345 mg/mLALOGPS
logP3.63ALOGPS
logP3.25Chemaxon
logS-2.8ALOGPS
pKa (Strongest Acidic)4.67Chemaxon
pKa (Strongest Basic)-2.8Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area57.53 Å2Chemaxon
Rotatable Bond Count10Chemaxon
Refractivity60.2 m3·mol-1Chemaxon
Polarizability26.59 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9763
Blood Brain Barrier+0.768
Caco-2 permeable+0.6421
P-glycoprotein substrateSubstrate0.5
P-glycoprotein inhibitor INon-inhibitor0.9678
P-glycoprotein inhibitor IINon-inhibitor0.8318
Renal organic cation transporterNon-inhibitor0.9304
CYP450 2C9 substrateNon-substrate0.8199
CYP450 2D6 substrateNon-substrate0.8732
CYP450 3A4 substrateNon-substrate0.6643
CYP450 1A2 substrateInhibitor0.5446
CYP450 2C9 inhibitorNon-inhibitor0.8213
CYP450 2D6 inhibitorNon-inhibitor0.911
CYP450 2C19 inhibitorNon-inhibitor0.8965
CYP450 3A4 inhibitorNon-inhibitor0.8825
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9089
Ames testNon AMES toxic0.972
CarcinogenicityNon-carcinogens0.7301
BiodegradationReady biodegradable0.8944
Rat acute toxicity1.3109 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9467
hERG inhibition (predictor II)Non-inhibitor0.8622
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-000f-9500000000-ce0e4abc46c623ad5053
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-00ks-9610000000-f7e3aee6b864966cb573
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-066r-5090000000-8b6f5c222681a01fa8ae
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-9410000000-dc4972feabd76b7c0c52
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0avi-9000000000-baac32edf1ea32694484
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4l-9100000000-5c40fdb1609bd8811b55
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4l-9000000000-62e04cfb1d0e64168138
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-167.7390739
predicted
DarkChem Lite v0.1.0
[M-H]-168.6827739
predicted
DarkChem Lite v0.1.0
[M-H]-166.9524739
predicted
DarkChem Lite v0.1.0
[M-H]-148.27058
predicted
DeepCCS 1.0 (2019)
[M+H]+168.1534739
predicted
DarkChem Lite v0.1.0
[M+H]+168.4074739
predicted
DarkChem Lite v0.1.0
[M+H]+166.8929739
predicted
DarkChem Lite v0.1.0
[M+H]+151.1077
predicted
DeepCCS 1.0 (2019)
[M+Na]+167.2038739
predicted
DarkChem Lite v0.1.0
[M+Na]+168.3267739
predicted
DarkChem Lite v0.1.0
[M+Na]+166.1711739
predicted
DarkChem Lite v0.1.0
[M+Na]+159.45895
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Receptor binding
Specific Function
Catalyzes the desaturation of acyl-CoAs to 2-trans-enoyl-CoAs. Isoform 1 shows highest activity against medium-chain fatty acyl-CoAs and activity decreases with increasing chain length. Isoform 2 i...
Gene Name
ACOX1
Uniprot ID
Q15067
Uniprot Name
Peroxisomal acyl-coenzyme A oxidase 1
Molecular Weight
74423.035 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at September 15, 2010 21:27 / Updated at June 12, 2020 16:52